These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17504831)

  • 1. Advances in gastrointestinal pharmacotherapy--who would have thought?
    Berardi RR
    Ann Pharmacother; 2007 Jun; 41(6):1053-5. PubMed ID: 17504831
    [No Abstract]   [Full Text] [Related]  

  • 2. [Motility-modifying drugs].
    Storr M; Allescher HD
    Internist (Berl); 2000 Dec; 41(12):1318-24, 1326-30. PubMed ID: 11189067
    [No Abstract]   [Full Text] [Related]  

  • 3. [Problems of long-term therapy and therapeutic damage considering the clinical aspects. Gastroenterology].
    Dölle W
    Verh Dtsch Ges Inn Med; 1991; 97():63-70. PubMed ID: 1808956
    [No Abstract]   [Full Text] [Related]  

  • 4. How drugs act. Drugs and the gastrointestinal tract.
    Smith S
    Nurs Times; 1987 Jul 1-7; 83(26):50-2. PubMed ID: 3649751
    [No Abstract]   [Full Text] [Related]  

  • 5. Emerging diseases of the gastrointestinal tract. Preface.
    Kuipers EJ
    Best Pract Res Clin Gastroenterol; 2009; 23(1):1-2. PubMed ID: 19258181
    [No Abstract]   [Full Text] [Related]  

  • 6. Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders.
    Pasricha PJ
    Gastroenterology; 2007 Jun; 132(7):2287-90. PubMed ID: 17570201
    [No Abstract]   [Full Text] [Related]  

  • 7. Lactose content of gastrointestinal drugs: does it matter?
    Guslandi M
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1212; author reply 1213. PubMed ID: 19473126
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in GI pharmacology and therapeutics.
    Scarpignato C; Di Mario F
    Dig Dis; 2006; 24(1-2):7-10. PubMed ID: 16699261
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-induced acute pancreatitis related to medications commonly used in gastroenterology.
    Ksiądzyna D
    Eur J Intern Med; 2011 Feb; 22(1):20-5. PubMed ID: 21238888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatotoxicity of drugs used in the treatment of gastrointestinal disorders.
    Bashir RM; Lewis JH
    Gastroenterol Clin North Am; 1995 Dec; 24(4):937-67. PubMed ID: 8749906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cisapride.
    Mathew A
    Indian Pediatr; 2000 Dec; 37(12):1402-4. PubMed ID: 11119361
    [No Abstract]   [Full Text] [Related]  

  • 12. Minor digestive disturbances.
    Copper P
    Midwife Health Visit Community Nurse; 1977 Aug; 13(8):263. PubMed ID: 587248
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gastrointestinal motility disorders and drugs: cholinergic, anticholinergic, adrenergic, antiadrenergic and prokinetic drugs (part I)].
    Jovanović-Mićić D; Janković S; Beleslin DB
    Srp Arh Celok Lek; 1994; 122(1-2):50-4. PubMed ID: 17972806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access options for withdrawn motility-modifying agents.
    Jones MP
    Am J Gastroenterol; 2002 Sep; 97(9):2184-8. PubMed ID: 12358230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of digestive disorders of different etiology].
    Klobe R
    Z Allgemeinmed; 1972 Apr; 48(11):566-7. PubMed ID: 5067948
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of drugs for gastrointestinal motor disorders: translating science to clinical need.
    Sanger GJ; Alpers DH
    Neurogastroenterol Motil; 2008 Mar; 20(3):177-84. PubMed ID: 18257767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary and gastrointestinal systems medications.
    Schryvers O; Nance PW
    Phys Med Rehabil Clin N Am; 1999 May; 10(2):473-92, ix-x. PubMed ID: 10370942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experiences with a new antidiarrhea agent in general practice].
    Metzger C
    Med Monatsschr; 1971 Jan; 25(1):39-40. PubMed ID: 5546755
    [No Abstract]   [Full Text] [Related]  

  • 19. Ion channels as targets for treatment of gastrointestinal motility disorders.
    Farrugia G
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():135. PubMed ID: 18924455
    [No Abstract]   [Full Text] [Related]  

  • 20. Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life.
    Kalaitzakis E; Björnsson E
    Hepatology; 2007 Sep; 46(3):949-50; author reply 951. PubMed ID: 17879365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.